Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Dabrafenib patent expiration date novartis gsk composition matter?Complera manufacturer?Symbravo ingredients mechanism of action?Xenazine current manufacturer 2025?
See the DrugPatentWatch profile for xifaxan
Xifaxan (rifaximin) was approved and came out in the U.S. in 2004 for treating traveler’s diarrhea caused by noninvasive strains of E. coli. [1]
Yes. After the original approval in 2004, Xifaxan later gained additional FDA-approved indications (for example, for hepatic encephalopathy), but the first U.S. launch for any Xifaxan use was in 2004. [1]
If you’re asking about the brand’s start date (its initial market entry in the U.S.), the answer is 2004. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Xifaxan :